Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines a

Details Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines a Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines a

1996-08-22

1998-08-25

Reamer, James H.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546201, A61K 3144

Patent

active

057983682

ABSTRACT:
Tetrasubstituted 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines reduce the levels of TNF.alpha. in a mammal. A typical embodiment is 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4,5,6,7-tetrafluoroisoindoline.

REFERENCES:
patent: 4590189 (1986-05-01), Hiraga et al.
patent: 4849441 (1989-07-01), Okazaki et al.
patent: 5385901 (1995-01-01), Kaplan et al.
patent: 5502666 (1996-03-01), Heinemann et al.
patent: 5593990 (1997-01-01), D'Amato

Affiliated with

Also associated with

Rating

Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrasubstituted 2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolines a will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-36592